Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Analytical Laboratory Services
... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing Services, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More
-
Blood Screening
... CAGR of 5.5% over the analysis period 2024-2030. Blood Screening Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end ... Read More
-
Cancer Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. ... Read More
-
Blood Transfusion Devices
... at a CAGR of 5.8% over the analysis period 2024-2030. Pathogen Reduction System, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion by the end ... Read More
-
Breast Lesion Localization
... at a CAGR of 4.5% over the analysis period 2024-2030. Breast Biopsy, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$309.2 Million by the end of ... Read More
-
Blood Banking and Blood Products
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More
-
Anatomic Pathology
... CAGR of 5.8% over the analysis period 2024-2030. Anatomic Pathology Services, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$36.4 Billion by the end of the ... Read More
-
Teleradiology
... 17.2% over the analysis period 2024-2030. X-ray, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth in ... Read More
-
Therapeutic Plasma Exchange
... at a CAGR of 6.2% over the analysis period 2024-2030. Neurological Disorders Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million by the end ... Read More
-
Vascular Imaging
... CAGR of 4.7% over the analysis period 2024-2030. MRI Technique, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$5.5 Billion by the end of the analysis ... Read More
-
Bio-MEMS
... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the ... Read More
-
Digital Radiography
... CAGR of 5.9% over the analysis period 2024-2030. Computed Radiography (CR), one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$17.0 Billion by the end of the ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
-
Women`s Health Diagnostics
... at a CAGR of 5.8% over the analysis period 2024-2030. Breast Cancer Testing, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$11.3 Billion by the end ... Read More
-
MRI Compatible Pacemaker
... at a CAGR of 4.0% over the analysis period 2024-2030. Arrhythmias Application, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Acute Ischemic Stroke Diagnosis and Treatment
... reach US$3.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Computed Tomography Diagnosis, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and ... Read More
-
Biomedical Refrigerators and Freezers
... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Ultra Low Temperature (ULT) Freezers, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$533.2 ... Read More
-
Exocrine Pancreatic Insufficiency
... at a CAGR of 5.8% over the analysis period 2024-2030. Exocrine Pancreatic Insufficiency Therapeutics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.8 Billion by the ... Read More
-
Endoscopic Ultrasound Needles
... at a CAGR of 2.7% over the analysis period 2024-2030. Aspiration Needles (EUS-FNA), one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$150.5 Million by the end ... Read More
-
Automated Immunoassay Analyzers
... at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Blood Cell Analyzer
... at a CAGR of 4.8% over the analysis period 2024-2030. Semi-Automated Biochemistry Analyzers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$687.6 Million by the end ... Read More
-
Cytology Brushes
... CAGR of 6.1% over the analysis period 2024-2030. Metal Brushes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$71.9 Billion by the end of the analysis ... Read More
Research Assistance
